Advertisement

Neurobiologische Grundlagen der Zwangsstörung

  • M. Aigner
Conference paper

Zusammenfassung

Nur durch Beachtung sozialer, psychologischer und biologischer Faktoren und ihrer Wechselwirkungen kann die Zwangsstörung verstanden werden (Ecker 1995, Tallis 1995). Die Gültigkeit neurobiologischer Modelle der Zwangsstörung wird gegenwärtig noch kontrovers diskutiert (Wurthmann und Bondick 1995, Brody und Saxena 1996). Neuromorphologische Veränderungen können nur bei einer Subgruppe von ZwangspatientInnen gefunden werden (Tabelle 1).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adams BL, Warneke LB, McEwan AJB et al. (1993) Single photon emission computerized tomography in obsessive-compulsive disorder: a preliminary study. J Psychiatr Neurosci 18: 109–112.Google Scholar
  2. Alexander GE, Crutcher MD, DeLong MR (1990) Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculommotor, „prefrontal” and „limbic” functions. Prog Brain Res 85: 119.PubMedCrossRefGoogle Scholar
  3. Aylward EH, Harris GJ, Hoehn-Saric R, Barta PE, Machlin SR, Pearlson GD (1996) Normal caudate nucleus in obsessive-compulsive disorder assessed by quantitative neuroimaging. Arch Gen Psychiatry 53: 577–84.PubMedGoogle Scholar
  4. Barnes JM, Barnes NM, Costall B (1989) 5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue. Nature 338: 762.Google Scholar
  5. Baumgarten HG, Grozdanovic Z (1995) Die Rolle des Serotonins in der Verhaltensmodulation. Fortschr Neurol Psychiat 63 [Sonderheft 1]: 3.PubMedCrossRefGoogle Scholar
  6. Baxter LR Jr, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE (1987) Local cerebral glucose metabolism rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry 44: 211–8.Google Scholar
  7. Baxter LR, Schwärzt JM, Mazziotta JC et al. (1988) Cerebral glucose metabolic rates in non-depressed obsessive-compulsives. Am J Psychiatry 145: 1560–1563PubMedGoogle Scholar
  8. Baxter LR, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, Alazraki A, Selin CE, Fereng HK, Munford P, Phelps ME (1992) Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 49: 681–689.PubMedGoogle Scholar
  9. Behar D, Rapoport JL, Berg CJ et al. (1984) Computerized tomography and neuropsychological test measures in adolescents with obsessive-compulsive disorder. Am J Psychiatry 141: 363–369.PubMedGoogle Scholar
  10. Benkelfat C, Nordahl TE, Semple WE, King AC, Murphy DL, Cohen AM (1990) Local cerebral glucose metabolic rates in obsessive-compulsive disorder: patients treated with clomipramine. Arch Gen Psychiatry 47: 840–848PubMedGoogle Scholar
  11. Breiter HC, Rauch SL, Kwong KK, Baker JR, Weisskoff RM, Kennedy DN, Kendrick AD, Davis TL, Jiang A, Cohen MS, Stern CE, Belliveau JW, Baer L, Sullivan RL, Savage CR, Jenike MA, Rosen BR (1996) Functional magnetic resonance imaging of symptomprovocation in obsessive-compulsive disorder. Arch Gen Psychiatry 53: 595PubMedGoogle Scholar
  12. Brody AL, Saxena S (1996) Brain imaging in obsessive-compulsive disorder: evidence for the involvement of frontal-subcortical circuitry in the mediation of symptomatology. CNS Spectrums 1: 27.Google Scholar
  13. Calabrese G, Colomvo C, Bonfanti A, Scotti G, Sscarone S (1993) Caudate nucleus abnormalities in obsessive-compulsive disorder: measurements of MRI signal intensity. Psychiatry Res 50 (2): 89–92PubMedCrossRefGoogle Scholar
  14. Ecker W (1995) Kontrollzwänge und Handlungsgedächtnis. Theorie und Forschung, Bd 380. Psychologie, Bd 128. Roderer, Regensburg.Google Scholar
  15. Fux M, Levine J, Aviv A, Belmaker RH (1996) Inositol treatment of obsessive-compulsive disorder. Am J Psychiatry 153: 1219PubMedGoogle Scholar
  16. Garber HJ, Anath JV, Chiu LC, Griswold VJ, Oldendorf WH (1989) Nuclear magnetic resonance study of obsessive-compulsive disorder. Am J Psychiatry 146: 1001–1005.PubMedGoogle Scholar
  17. Hagan RM, Butler A, Hill JM (1987) Effect of the 5-HT3 receptor antagonist GR 38032F on response to injection of a neurokinin antagonist into the ventral tegmental area of the rat brain. Eur J Pharmacol 138: 303.PubMedCrossRefGoogle Scholar
  18. Hay P, Sachdev P, Cumming S, Smith JS, Lee T, Kitchener P, Matheson J (1993) Treatment of obsessive- compulsive disorder by psychosurgery. Acta Psychiatr Scand 87: 197.PubMedCrossRefGoogle Scholar
  19. Hoehn-Saric R, Pearlson GD, Harris GJ et al. (1991) Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients. Am J Psychiatry 48: 1243–1245.Google Scholar
  20. Insel TR (1992) Torward a Neuroanatomy of obsessive-compulsive disorder. Arch Gen Psychiatry 49: 681Google Scholar
  21. Insel TR, Donnelly EF, Lalakea ML et al. (1983) Neurological and neuropsychological studies of patients with obsessive-compulsive disorder. Biol Psychiatry 18: 741–751.PubMedGoogle Scholar
  22. Jenike MA, Breiter HC, Baer L, Kennedy DN et al. (1996) Cerebral structural abnormalities in obsessive- compulsive disorder. A quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry 53: 625–632Google Scholar
  23. Kellner CH, Jolley RR, Holgate RC, Austin L, Lydiard RB, Laraia M, Ballenger JC (1991) Brain MRI in obsessive-compulsive disorder. Psychiatry Res 36: 45–49.PubMedCrossRefGoogle Scholar
  24. Künzle H (1994) Aufbau und Verbindungen der Basalganglien. In: Drenckhahn D, Zenker W (Hrsg) Benninghoff Anatomie, 15- Aufl, Bd I I. Urban und Schwarzenberg, München Wien Baltimore.Google Scholar
  25. Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, Anderson GM, Riddle MA, McSwiggan-Hardin M, McDougle CJ (1994a) Elevated cerebrospinal fluid levels of oxytocin in obsessive- compulsive disorder. Comparison withTourette’s syndrome and healthy controls. Arch Gen Psychiatry 51: 782.Google Scholar
  26. Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, Anderson GM, Riddle MA, McDougle CJ, Barr LC, Cohen DJ (1994b) The role of central oxytocin in obsessive compulsive disorder and related normal behavior. Psychoneuroendocrinology 19: 1.CrossRefGoogle Scholar
  27. Lucey JV, Costa DC, Blanes T, Busatto GF, Pilowsky LS, Takei N, Marks IM, Ell PJ, Kerwin RW (1995) Regional cerebral blood flow in obsessive-compulsive disordered patients at rest. Differential correlates with obsessive-compulsive and anxious-avoidant dimensions. Br J Psychiatry 167: 629–34.Google Scholar
  28. Luxenberg JS, Swedo SE, Flamant MF et al. (1988) Neuroanatomical abnormalities in obsessive-compulsive disorder determined with quantitative x-ray computed tomography. Am J Psychiatry 145: 1089–1093PubMedGoogle Scholar
  29. Machlin S, Harris G, Pearslon G, Hoehn-Saric R, Jeffery P, Camargo E (1991) Elevated medical-frontal cerebral blood flow in obsessive-compulsive patients: a SPECT study. Am J Psychiatry 148: 1240–1242.PubMedGoogle Scholar
  30. Martinot JL, Allilaire JF, Mazoyer BM, Hantouche E, Huret JD, Legaut Demare F, Deslauriers AG, Hardy P, Pappata S, Baron JC et al. (1990) Obsessive-compulsive disorder: a clinical, neurophysical and positron emission tomography study. Acta Psychiatr Scand 82 (3): 233–42.PubMedCrossRefGoogle Scholar
  31. Nordahl TE, Benkelfat C, Semple WE, Gross M, King AC, Cohen RM (1989) Cerebral glucose metabolismrates in obsessivee compulsive disorder. Neuropsychopharmacology 2: 23–8.PubMedCrossRefGoogle Scholar
  32. Petty F, Davis LL, Kabel D, Kramer GL (1996) Serotonin dysfunction disorders: a behavioral neurochemistry perspective. J Clin Psychiatry 57 [Suppl 8]: 11.PubMedGoogle Scholar
  33. Rapoport JL (1990) Obsessive compulsive disorder and basal gangla dysfunction. Psychol Med 20: 465PubMedCrossRefGoogle Scholar
  34. Rauch SL, Jenike MA, Alpert NM (1994) Regional cerebral blood flow measured during symptom provocation in obsessive. Compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 51: 62.PubMedGoogle Scholar
  35. Rubin RT, Villanueva-Meyer J, Ananth J, Trajmar PG, Mena I (1992) Regional xenon 133 cerebral blood flow and cerebral technetium 99mHMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by high-resolution single-photon emission computed tomography. Arch Gen Psychiatry 49: 695–702.Google Scholar
  36. Rubin RT, Ananth J, Villanueva-Meyer J, Trajmar PG, Mena I (1995) Regional 133xenon cerebral blood flow and cerebral 99mTc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment. Biol Psychiatry 38: 429–37.PubMedCrossRefGoogle Scholar
  37. Rutter JJ, Gundlah C, Auerbach SB (1994) Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetin. Neurosci Lett 171: 183.PubMedCrossRefGoogle Scholar
  38. Scarone S, Colombo C, Livian S et al. (1992) Increased right caudate nucleus size in obsessive-compulsive disorder: detection with magentic resonance imaging. Psychiatry Res 45: 115–121.PubMedCrossRefGoogle Scholar
  39. Swedo SE, Schapiro MB, Grady CL, Cheslow DL, Leonard HL, Kumar A, Friedland R, Rapoport SI, Rapoport JL (1989) Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry 46: 518–23.PubMedGoogle Scholar
  40. Swedo SE, Pietrini P, Leonard HL, Schapiro MB, Rettew DC, Goldberger El, Rapoport SI, Rapoport JL, Grady CL (1992) Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Arch Gen Psychiatry 9: 690–4.Google Scholar
  41. Schwartz JM, Stoessel PW, Baxter LR Jr, Martin KM, Phelps ME (1996) Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 53: 109–113PubMedGoogle Scholar
  42. Szabo Z, Kao PF, Scheffel U, Suehiro M, Mathews WB, Ravert HT, Musachio JL, Marenco S, Kim SE, Ricaurte GA, Wong DF, Wagner HN, Dannais RF (1995) Positron emission tomography imaging of serotonin transporters in the human brain using [1 1C](+)McN5652. Synapse 20: 37.PubMedCrossRefGoogle Scholar
  43. Talairach J, Bancand J, Geier S et al. (1973) The cingulate gyrus and human behavior. Electroencephalogr Clin Neurophysiol 34: 45–52PubMedCrossRefGoogle Scholar
  44. Tallis F (1995) Obsessive compulsive disorder. A cognitive and neuropsychological perspective. J Wiley & Sons, ChichesterGoogle Scholar
  45. Wurthmann C, Bondick I (1995) Zur Gültigkeit des neuroethologischen Modells der Zwangsstörung. Fortschr Neurol Psychiat 63: 121.PubMedCrossRefGoogle Scholar
  46. Zald DH, Kim SW (1996) Anatomy and function of the orbital frontal cortex, I. Anatomy, neurocircuitry, and obsessive-compulsive disorder. J Neuropsychiatry 8: 125.Google Scholar
  47. Zitterl W, Wimberger D, Demal U, Hofer E, Lenz G (1994) Nuclear magnetic resonance tomography findings in obsessive-compulsive disorder. Nervenarzt 65 (9): 619–22.PubMedGoogle Scholar
  48. Zohar J, Insel TR, Berman KF et al. (1989) Anxiety and cerebral blood flow during behavioral challenge: dissociation of central from peripheral and subjective measures. Arch Gen Psychiatry 46: 505–510PubMedGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1998

Authors and Affiliations

  • M. Aigner

There are no affiliations available

Personalised recommendations